The Trump administration is considering changes to the Advisory Committee on Immunization Practices (ACIP), a key group that advises on U.S. vaccine policies. This comes after a lawsuit claimed that recent appointments to the committee violated federal rules. A judge agreed, blocking these appointments and halting ACIP’s work. The administration might disband and reform the committee to address these legal issues. The future of ACIP and its impact on vaccine recommendations is uncertain, as the administration has not confirmed its next steps. This situation is important because it affects how vaccines are recommended and could influence public health.
QUESTION: How might changes to the way vaccine advisory committees are formed impact public trust in vaccines and health recommendations?
Influential vaccine advisory panel ACIP may be ‘disbanded’ after lawsuit, says former vice chair
